ID
32581
Description
Study ID: 106837 Clinical Study ID: HZA106837 Study Title: A Long-Term, Randomized, Double-Blind, Parallel Group Study of Fluticasone Furoate/GW642444 Inhalation Powder Once-Daily and Fluticasone Furoate Inhalation Powder Once-Daily in Subjects with Asthma Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT01086384 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 3 Study Recruitment Status: Completed Generic Name: fluticasone furoate/vilanterol Trade Name: Relvar Study Indication: Asthma
Keywords
Versions (2)
- 11/7/18 11/7/18 -
- 12/7/18 12/7/18 -
Copyright Holder
GSK group of companies
Uploaded on
November 7, 2018
DOI
To request one please log in.
License
Creative Commons BY-NC 3.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
A Parallel Group Study of Fluticasone Furoate/Vilanterol in Subjects with Asthma - 106837
Diary Card 2: Medical Problems - Visit 1-12
- StudyEvent: ODM
Description
Medical problem
Description
Record all medical problem(s) you have experienced AND record all medication(s) you took on that date to treat the problem(s). Do NOT include study-related medications
Data type
text
Description
Date Medical Problem Started
Data type
date
Description
Date Medical Problem Stopped
Data type
date
Description
Medications Taken for Medical Problem
Data type
text
Description
Date Medication Started
Data type
date
Description
Date Medication Stopped
Data type
date
Similar models
Diary Card 2: Medical Problems - Visit 1-12
- StudyEvent: ODM